{reportSlug=global-postmenopausal-vaginal-atrophy-treatment-market, reportId=75039, mktKeyword=Postmenopausal Vaginal Atrophy Treatment, cagr=0.00, publishDate=Jan 2024, priceOption2=6800, reportTitle=Postmenopausal Vaginal Atrophy Treatment Comprehensive Study by Type (Prasterone (Intrarosa)), Application (Vaginal estrogen cream (Estrace, Premarin). You insert this cream directly into your vagina with an applicator, usually at bedtime. ..., Vaginal estrogen suppositories (Imvexxy)., Vaginal estrogen ring (Estring, Femring, Vaginal estrogen tablet (Vagifem).), Drug Form (Vaginal gel, Creams, Tablet, Others), Drug (Estrogen based drugs (Premarin, Vagifem, Estrace, Estring and Femring), Non-estrogen based drugs (BZA/CE, Osphena, and Vaginorm), Others), Route of Administration (Oral, Intravaginal, Others), End User (Hospitals, Specialty Clinics, Others) Players and Region - Global Market Outlook to 2029, baseYr=2023, totalTableFig=175, priceOption1=3650, forecastYr=2029, noOfPages=232, reportKey=74642, breadcrum=Global Postmenopausal Vaginal Atrophy Treatment}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Jan 2024
232 Pages
65 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries